Deciphera Pharmaceuticals Inc (DCPH)
25.46
+0.02
(+0.06%)
USD |
NASDAQ |
May 17, 16:00
25.46
0.00 (0.00%)
After-Hours: 20:00
Deciphera Pharmaceuticals Gross Profit (TTM): 169.58M for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 169.58M |
| December 31, 2023 | 159.62M |
| September 30, 2023 | 146.22M |
| June 30, 2023 | 136.82M |
| March 31, 2023 | 129.38M |
| December 31, 2022 | 125.27M |
| September 30, 2022 | 115.85M |
| June 30, 2022 | 105.52M |
| March 31, 2022 | 97.12M |
| Date | Value |
|---|---|
| December 31, 2021 | 93.22M |
| September 30, 2021 | 88.89M |
| June 30, 2021 | 81.95M |
| March 31, 2021 | 66.73M |
| December 31, 2020 | 41.86M |
| September 30, 2020 | 22.50M |
| June 30, 2020 | 7.144M |
| March 31, 2020 | 25.06M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
7.144M
Minimum
Jun 2020
169.58M
Maximum
Mar 2024
94.87M
Average
97.12M
Median
Mar 2022
Gross Profit (TTM) Benchmarks
| Bristol-Myers Squibb Co | 34.48B |
| Dynavax Technologies Corp | 189.73M |
| Gilead Sciences Inc | 20.80B |
| Esperion Therapeutics Inc | 188.05M |
| SINTX Technologies Inc | 0.406M |